Overview
- 7 inspections across 7 sites are on record.
- 38 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-29.
At a glance
Inspections
7
Sites
7
Observations
38
Career since
Oct 2022
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Samson Pharmaceuticals, Inc | 29 Apr 2026 | Human Drugs | View 483 → |
| K.C. Pharmaceuticals, Inc | 13 Feb 2026 | Human Drugs | View 483 → |
| Actavis Laboratories UT, Inc. | 19 Sep 2025 | Human Drugs | View 483 → |
| Central Admixture Pharmacy Services, Inc. | 5 Sep 2025 | Human Drugs | View 483 → |
| Glenmark Pharmaceuticals Inc USA | 17 Jun 2025 | Human Drugs | View 483 → |
Sites inspected
Samson Pharmaceuticals, IncCommerce, United States1 insp.
K.C. Pharmaceuticals, IncPomona, United States1 insp.
Actavis Laboratories UT, Inc.Salt Lake City, United States1 insp.
Central Admixture Pharmacy Services, Inc.Allentown, United States1 insp.
Glenmark Pharmaceuticals Inc USAMonroe, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Walden H Lee2 shared
Ngozi G Offor1 shared
Nathan E Hellman1 shared
Pearl C Ozuruigbo1 shared
Rowena S Nguyen1 shared
Crystal Monroy1 shared
Truong X Nguyen1 shared
Taichun Qin1 shared
Homero W Aguilar1 shared
Damaris Y Hernandez1 shared
Full investigator report
Get the verbatim findings behind Luis P Torres' 38 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site